| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |